Interesting post. As for a CR no one really knows when one would come but most companies like at least 2 quarters free. Go for performance, say they were to replace the cash spent last quarter, could they raise to cover this at say 12 cents next 10 followed by 7 and then 5.
Luck could play a part. Good trial and things may be diffrent. Note however the sneak peak didnot lift the SP.
Cash burn rate. This unfortunatly has to go way up. The cost of trials is actualy small when you look at the development cost. By far the biggest spend is on the development of the tech. Your x boss said that manufacturing was not cheap. Well to go 3D and this is Cyp's game plan you are going to need 100s of millions.
I would link a patent of 3D manufacturing that shows the work and volums needed to validate the many processes but that would be cross promotion. I will say the first step is about 10 runs of 20 l. But that is just the first of many.
- Forums
- ASX - By Stock
- Ann: Quarterly Activity Report & Appendix 4C
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.0¢

Interesting post. As for a CR no one really knows when one would...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $1.021K | 6.379K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 3400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 77738 | 0.160 |
4 | 148709 | 0.155 |
4 | 86673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 3400 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 146968 | 5 |
0.185 | 35990 | 1 |
Last trade - 09.59am 24/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |